Rectal resection following neoadjuvant therapy in a midwest community hospital setting: The case for standardization over centralization as the means to optimize rectal cancer outcomes in the United States

2019 ◽  
Vol 217 (3) ◽  
pp. 435-436
Keyword(s):  
United States ◽  
Rectal Cancer ◽  
Neoadjuvant Therapy ◽  
Community Hospital ◽  
Rectal Resection ◽  
Hospital Setting ◽  
The United States ◽  
Cancer Outcomes

Submit Manuscript | http://medc rav eonline.co m Introduction Colorectal adenocarcinoma is the third most common malignant neoplasia and the third leading cause of death from cancer in men and women in the United States. Current data show that the incidence of colorectal adenocarcinoma is decreasing in developed countries but increasing in developing countries. 1 The 2018 estimates of the Bra - zilian National Cancer Institute (Instituto Nacional do Câncer–INCA) were 17,380 new cases in men and 18,980 in women, making col - orectal adenocarcinoma the third most common neoplasia in men and the second most common in women in Brazil. 2 In the past 15 years, rectal cancer management has evolved in several aspects. Specifical - ly, a better understanding of the natural history of the disease, more precise radiological staging, multimodal therapeutic intervention, refined surgical techniques, and more detailed histopathological re - ports may have positively influenced patient survival. In this context, multidisciplinary management of colorectal cancer plays an important role and requires the coordinated teamwork of colorectal surgeons, oncologists, radiologists, and radiotherapists. 3 Total mesorectal exci - sion is still the basis of treatment in rectal cancer. However, neoadju - vant therapy and more conservative practices have been adopted in cases of clinical/pathological responses to radiochemotherapy. 4 Ra - diological evaluation of the response is of paramount importance for the selection of patients eligible for alternative treatment strategies, including ‘watch-and-wait’. Diffusion-weighted imaging is already being used routinely in the evaluation of the pathological response of rectal tumour patients submitted to neoadjuvant therapy. Some re - searchers have tried to estimate the tumour regression grade (TRG) using magnetic resonance imaging, as has been described for post-ra - diochemotherapy pathological evaluation, thus rendering it a valuable instrument. Considering the good results obtained with multimodal therapy in extraperitoneal rectal cancer, the evaluation of the pathological re - sponse post-neoadjuvant therapy must be considered as a factor for safe indication, both for the conservative option, in which the organ is preserved, and for radical surgical resection, influencing the choice between sphincter-preserving surgery and abdominoperineal excision. A precise evaluation, by comparing the results of post-neoadjuvant therapy magnetic resonance imaging with those obtained from his - Int J Radiol Radiat Ther. 2018;5(4):254 ‒ 258. 254 © 2018 Oliveira et al. This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and build upon your work non-commercially. Magnetic resonance imaging is effective in assessing tumour regression after neoadjuvancy in rectal adenocarcinoma

2018 ◽  
Vol 5 (4) ◽  
Author(s):  
Fábio Henrique de Oliveira ◽  
Antônio Lacerda-Filho ◽  
Fábio Lopes de Queiroz ◽  
Tatiana Martins Gomide Leite ◽  
Paulo Guilherme Oliveira Sales ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Rectal Cancer ◽  
Magnetic Resonance ◽  
Neoadjuvant Therapy ◽  
Colorectal Adenocarcinoma ◽  
The United States ◽  
Tumour Regression ◽  
Resonance Imaging ◽  
Cancer Management ◽  
The Third

Multi-practice survey on MR imaging practice patterns in rectal cancer in the United States

2021 ◽  
Author(s):  
David D. B. Bates ◽  
Hiram Shaish ◽  
Marc J. Gollub ◽  
Mukesh Harisinghani ◽  
Chandana Lall ◽  
...  
Keyword(s):  
United States ◽  
Rectal Cancer ◽  
Mr Imaging ◽  
Practice Patterns ◽  
The United States ◽  
Practice Survey

scholarly journals Identification and Management of Sepsis in the Interventional Radiology Patient

2017 ◽  
Vol 1 ◽  
pp. 3
Author(s):  
Jacqueline Murtha ◽  
Vinit Khanna ◽  
Talia Sasson ◽  
Devang Butani
Keyword(s):  
United States ◽  
Health Care ◽  
Septic Shock ◽  
Interventional Radiology ◽  
Hospital Setting ◽  
The United States ◽  
Clinical Aspects ◽  
Inhospital Mortality ◽  
United States Population ◽  
Hospital Acquired

Sepsis is frequently encountered in the hospital setting and can be community-acquired, health-care-associated, or hospital-acquired. The annual incidence of sepsis in the United States population ranges from 300 to 1031 per 100,000 and is increasing by 13% annually. There is an associated inhospital mortality of 10% for sepsis and >40% for septic shock. Interventional radiology is frequently called on to treat patients with sepsis, and in rarer circumstances, interventional radiologists themselves may cause sepsis. Thus, it is essential for interventional radiologists to be able to identify and manage septic patients to reduce sepsis-related morbidity and mortality. The purpose of this paper is to outline procedures most likely to cause sepsis and delineate important clinical aspects of identifying and managing septic patients.

scholarly journals Mortality from Circulatory Diseases and other Non-Cancer Outcomes among Nuclear Workers in France, the United Kingdom and the United States (INWORKS)

2017 ◽  
Vol 188 (3) ◽  
pp. 276 ◽  
Author(s):  
Michael Gillies ◽  
David B. Richardson ◽  
Elisabeth Cardis ◽  
Robert D. Daniels ◽  
Jacqueline A. O'Hagan ◽  
...  
Keyword(s):  
United States ◽  
United Kingdom ◽  
The United States ◽  
Cancer Outcomes ◽  
Nuclear Workers ◽  
The United Kingdom ◽  
Circulatory Diseases
Sign in / Sign up

Export Citation Format

Share Document